Background: Laser Anatomical Endoscopic Enucleation of the Prostate (LAEEP) techniques offer a promising solution for patients seeking to alleviate urinary symptoms while preserving sexual function. The ejaculation preservation approach has been shown to achieve an impressive 90% success rate in maintaining antegrade ejaculation.

Purpose: To explore the effect of the ejaculatory preservation HoLEP technique on postoperative continence and ejaculation.

Patients And Methods: We conducted a prospective randomized study adhering to CONSORT guidelines. Patients with prostate sizes between 40 and 80 gm, IPSS scores > 20, Qmax < 10 ml/s, and IIEF-5 scores  > 22 were eligible for inclusion. A total of 43 patients were randomized into two groups: Group 1 (n = 22) underwent HoLEP, while Group 2 (n = 21) underwent EP HoLEP. We assessed functional outcomes and ejaculatory dysfunction at baseline and 1-, 3-, and 6- month. The study period was from October 2022 to March 2024.

Results: Data from 40 patients were analyzed. Functional outcomes showed significant improvement in Group 1, with IPSS (median 12.5, P < 0.006) and Qmax (median 15, P < 0.04) at 3-month. ICIQ-UI SF scores showed a significant difference in the incontinence episodes (domain Q3), which were lower (P < 0.023) in Group 2 compared to Group 1 during the 1-month visit. MSHQ-EjD-SF scores were significantly higher in Group 2 at both 3- and 6- month (P < 0.01 and P < 0.02, respectively). IIEF-5 scores showed no significant difference between both groups during the study period.

Conclusion: Implementing the ejaculation preservation technique during HoLEP appears to improve early postoperative continence and preserve ejaculation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876214PMC
http://dx.doi.org/10.1007/s00345-024-05418-yDOI Listing

Publication Analysis

Top Keywords

ejaculatory preservation
8
preservation holep
8
underwent holep
8
functional outcomes
8
holep
5
randomized prospective
4
prospective trial
4
trial comparing
4
comparing ejaculatory
4
holep versus
4

Similar Publications

Introduction: Standard surgical options for Benign Prostatic Hyperplasia [BPH], despite their excellent functional outcomes, are associated with multiple side effects and require general/spinal anesthesia and hospitalization. In this scenario, Transperineal Laser Ablation of the Prostate [TPLA] emerged as an ultra-minimally invasive ejaculation-sparing procedure, showing promising functional results, with a good safety profile. This systematic review aimed to provide an overview of the current role of TPLA in clinical practice, focusing on operative setting, safety, and efficacy.

View Article and Find Full Text PDF

Objective: Sexual function preservation is a paramount concern for patients undergoing benign prostatic hyperplasia (BPH) surgery, increasingly recognized by physicians. Blue laser vaporization, a novel approach for BPH treatment, has yet to be thoroughly investigated for its effects on sexual function. This prospective study assesses the impact of blue laser vaporization on sexual function in BPH patients, focusing on patient perceptions.

View Article and Find Full Text PDF

Background: Laser Anatomical Endoscopic Enucleation of the Prostate (LAEEP) techniques offer a promising solution for patients seeking to alleviate urinary symptoms while preserving sexual function. The ejaculation preservation approach has been shown to achieve an impressive 90% success rate in maintaining antegrade ejaculation.

Purpose: To explore the effect of the ejaculatory preservation HoLEP technique on postoperative continence and ejaculation.

View Article and Find Full Text PDF

Introduction: Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common in aging men, significantly impacting quality of life and healthcare costs. While transurethral resection of the prostate (TURP) remains the traditional standard for treatment, minimally invasive surgical therapies (MISTs) like Rezum™ (water vapor thermal therapy, WVTT) and Urolift™ (prostatic urethral lift, PUL) have emerged as effective alternatives. Both methods promise symptom relief with minimal invasiveness, yet a comparative medico-economic analysis is lacking.

View Article and Find Full Text PDF

Expert consensus on Rezūm™: Indications, surgical technique and postoperative care.

BJUI Compass

February 2025

Benign Prostatic Hyperplasia and Reconstructive Urology Unit at the Fundació Puigvert Barcelona Spain.

Background: Lower urinary tract symptoms associated to benign prostatic hyperplasia (LUTS/BPH) is a growing condition in males associated to a high clinical, economic and humanistic burden. Currently, there is a wide range of therapeutic options, both pharmacological and surgical. In recent years, several minimally invasive therapies have emerged, but they still have limitations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!